Mouse GRO-beta (CXCL2) Recombinant
$70.00 – $2,700.00
| accession | P10889 |
| Source | Optimized DNA sequence encoding mouse GRO-beta CXCL2 mature chain was expressed in Escherichia Coli. |
| Molecular weight | Native mouse GRO-beta is generated by the proteolytic removal of the signal peptide and propeptide. The molecule has a calculated molecular mass of approximately 8kDa. Recombinant GRO-beta is a monomer protein consisting of 73 amino acid residue subunits, and migrates as an approximately 8kDa protein under non-reducing and reducing conditions in SDS-PAGE. |
| Purity | >95%, as determined by SDS-PAGE and HPLC |
| Biological Activity | Determined by its ability to chemoattract transfected CXCR2 cells using a concentration range of-100 ng/ml. |
| Protein Sequence | MAPPTCRLLS AALVLLLLLA TNHQATGAVV ASELRCQCLK TLPRVDFKNI QSLSVTPPGP HCAQTEVIAT LKGGQKVCLD PEAPLVQKII QKILNKGKAN |
| Endotoxin | Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than.1 ng/µg(1EU/µg). |
| Presentation | Recombinant GRO-beta/CXCL2 was lyophilized from a.2μm filtered concentrated (1mg/ml) solution inmM Tris, pH7.0. |
| Reconstitution | A quick spin of the vial followed by reconstitution in distilled water to a concentration not less than.1 mg/mL. This solution can then be diluted into other buffers |
| Storage | The lyophilized protein is stable for at least years from date of receipt at -20° C. Upon reconstitution, this cytokine can be stored in working aliquots at° -° C for one month, or at -20° C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles. |
| Usage | This cytokine product is for research purposes only.It may not be used for therapeutics or diagnostic purposes. |
| Interactor | Q2F862 |
| Biological Process | Chemotaxis |
| Biological Process | Inflammatory-response |
| Molecular function | Cytokine |
Methods
Rab27a promotes migration of neutrophils in vivo and in vitro.
|
Rab27a promotes migration of neutrophils in vivo and in vitro.
|
|
|
|